Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.

[1]  D. Leosco,et al.  Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. , 2005, European heart journal.

[2]  David M. Harris,et al.  Vascular Smooth Muscle Overexpression of G Protein–Coupled Receptor Kinase 5 Elevates Blood Pressure, Which Segregates With Sex and Is Dependent on Gi-Mediated Signaling , 2005, Circulation.

[3]  Joshua M Hare,et al.  Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. , 2005, Trends in cardiovascular medicine.

[4]  D. Burkhoff,et al.  Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. , 2005, Journal of the American College of Cardiology.

[5]  M. Boerries,et al.  Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. , 2004, The Journal of clinical investigation.

[6]  W. Koch,et al.  Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization. , 2004, Journal of molecular and cellular cardiology.

[7]  Xinqiang Han,et al.  Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. , 2004, Physiological genomics.

[8]  M. Oz,et al.  Ventricular Assist Devices as a Bridge to Transplant or Recovery , 2004, Cardiology.

[9]  O. Brodde β-Adrenergic receptors in failing human myocardium , 2004, Basic Research in Cardiology.

[10]  Differential regulation of Ca2+-dependent ATPase-activity in left ventricular myocardium during mechanical circulatory support. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  L. Miller,et al.  Alterations of gene expression in failing myocardium following left ventricular assist device support. , 2003, Physiological genomics.

[12]  M. Yacoub,et al.  Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. , 2003, European heart journal.

[13]  M. Yacoub,et al.  Bridge to recovery with the use of left ventricular assist device and clenbuterol. , 2003, The Annals of thoracic surgery.

[14]  W. Koch,et al.  Differential gene expression and genomic patient stratification following left ventricular assist device support. , 2003, Journal of the American College of Cardiology.

[15]  D. Bainbridge,et al.  Cardiopulmonary Bypass Decreases G Protein–Coupled Receptor Kinase Activity and Expression in Human Peripheral Blood Mononuclear Cells , 2003, Anesthesiology.

[16]  O. Frazier,et al.  Downregulation of Metabolic Gene Expression in Failing Human Heart before and after Mechanical Unloading , 2002, Cardiology.

[17]  A. Gerdes,et al.  Myocyte Redistribution of GRK2 and GRK5 in Hypertensive, Heart-Failure–Prone Rats , 2002, Hypertension.

[18]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[19]  G. Andersen,et al.  Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. , 2001, American journal of physiology. Heart and circulatory physiology.

[20]  A. Feldman,et al.  Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices , 2001, Circulation.

[21]  N. Smedira,et al.  Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.

[22]  N. Smedira,et al.  Mechanical unloading causes recovery of calcium cycling in the failing human heart. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  N. Smedira,et al.  Evolution and significance of HLA allosensitization during ventricular assist device support. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  D. Burkhoff,et al.  Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure , 2000, Circulation.

[25]  R. Lefkowitz,et al.  Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction , 2000 .

[26]  J. Holtz,et al.  Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. , 1999, Circulation.

[27]  G. Noon,et al.  Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. , 1999, Circulation.

[28]  M. Cho,et al.  Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression* , 1999, The Journal of Biological Chemistry.

[29]  D. Glower,et al.  Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction. , 1999, American journal of physiology. Heart and circulatory physiology.

[30]  R. Lefkowitz,et al.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.

[31]  Jv Booth Acute depression of myocardial β-adrenergic receptor signaling during cardiopulmonary bypass , 1998 .

[32]  S. Houser,et al.  Regression of cellular hypertrophy after left ventricular assist device support. , 1998, Circulation.

[33]  S. Houser,et al.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. , 1998, Circulation.

[34]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Ping,et al.  Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. , 1997, The American journal of physiology.

[36]  M. Oz,et al.  Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. , 1997, The Annals of thoracic surgery.

[37]  R. Smiley,et al.  Perioperative lymphocyte adenylyl cyclase function in the pediatric cardiac surgical patient. , 1996, Critical care medicine.

[38]  N. Dzimiri,et al.  RELATIONSHIP BETWEEN ALTERATIONS IN LYMPHOCYTE AND MYOCARDIAL β‐ADRENOCEPTOR DENSITY IN PATIENTS WITH LEFT HEART VALVULAR DISEASE , 1996, Clinical and experimental pharmacology & physiology.

[39]  H Harasaki,et al.  Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. , 1996, Journal of the American College of Cardiology.

[40]  J. Thomas,et al.  Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. , 1995, Circulation.

[41]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[42]  H Harasaki,et al.  Structural and left ventricular histologic changes after implantable LVAD insertion. , 1995, The Annals of thoracic surgery.

[43]  M. Böhm,et al.  Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. , 1994, Circulation research.

[44]  R. Lefkowitz,et al.  Structure and mechanism of the G protein-coupled receptor kinases. , 1993, The Journal of biological chemistry.

[45]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[46]  O. Brodde,et al.  Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. , 1986, Science.

[47]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.